文章：

肿瘤坏死因子-α抑制剂使用与恶性肿瘤风险：一项系统综述与患者水平荟萃分析

Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis

原文发布日期：24 January 2025

DOI: 10.3390/cancers17030390

类型: Article

开放获取: 是

英文摘要：

Over the last two decades, tumor necrosis factor-alpha inhibitors (TNF-Is) have become standard therapies for chronic inflammatory disorders, with an ongoing expansion of indications and off-label applications [...]

摘要翻译： 

过去二十年间，肿瘤坏死因子-α抑制剂已成为慢性炎症性疾病的标准化治疗方案，其适应症范围与超说明书应用持续扩展。

原文链接：

Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis